Metastatic Melanoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Recruiting
  • Melanoma
  • +3 more
  • Phoenix, Arizona
  • +24 more
2022-04-06
Apr 6, 2022
M
Recruiting
  • Metastatic Melanoma
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
2022-04-06
Apr 6, 2022
N
Not yet recruiting
  • Metastatic Melanoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Active, not recruiting
  • Metastatic Melanoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
M
Completed
  • Metastatic Melanoma
  • Palliative radiotherapy
  • Dabrafenib and trametinib (combination)
  • Darlinghurst, New South Wales, Australia
  • +2 more
2022-04-06
Apr 6, 2022
N
Suspended
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +7 more
2022-04-05
Apr 5, 2022
N
Active, not recruiting
  • Metastatic Melanoma
  • +22 more
  • Ipilimumab
  • +3 more
  • Birmingham, Alabama
  • +24 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +20 more
  • Pembrolizumab
  • Ziv-Aflibercept
  • Tampa, Florida
  • +8 more
2022-04-05
Apr 5, 2022
N
Active, not recruiting
  • Metastatic Melanoma
  • +7 more
  • Dabrafenib Mesylate
  • +4 more
  • Birmingham, Alabama
  • +848 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
2022-04-05
Apr 5, 2022
D
Not yet recruiting
  • Malignant Melanoma
  • +4 more
  • (no location specified)
2022-03-31
Mar 31, 2022
N
Active, not recruiting
  • Malignant Solid Neoplasm
  • +7 more
  • Phoenix, Arizona
  • +48 more
2022-03-31
Mar 31, 2022
A
Recruiting
  • Metastatic Melanoma
  • Hypofractionated Radiation Therapy (HFRT)
  • +2 more
  • Lancaster, Pennsylvania
  • +1 more
2022-03-30
Mar 30, 2022
I
Recruiting
  • Metastatic Melanoma
  • Miami, Florida
  • +4 more
2022-03-29
Mar 29, 2022
N
Active, not recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +8 more
  • Dabrafenib Mesylate
  • +2 more
  • Los Angeles, California
  • +15 more
2022-03-25
Mar 25, 2022
I
Recruiting
  • Metastatic Melanoma
  • +2 more
  • Lifileucel
  • +5 more
  • La Jolla, California
  • +44 more
2022-03-23
Mar 23, 2022
N
Recruiting
  • Ovarian Cancer, Epithelial
  • +13 more
  • Sutton, Surrey, United Kingdom
  • +3 more
2022-03-22
Mar 22, 2022
P
Recruiting
  • Cancer Metastatic to the Liver
  • +9 more
  • PV-10 (10% rose bengal disodium)
  • San Diego, California
  • +4 more
2022-03-22
Mar 22, 2022
M
Completed
  • Metastatic Malignant Neoplasm in the Brain
  • +4 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-21
Mar 21, 2022
M
Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Quality-of-Life Assessment
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-08
Mar 8, 2022
F
Active, not recruiting
  • Metastatic Melanoma
  • Boston, Massachusetts
  • +1 more
2022-03-22
Mar 22, 2022